Montelukast Prescribing at MARK STREET SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
1,000
Total Quantity
36.4K
NHS Cost
£1.9K
vs National Avg
+46%
MARK STREET SURGERY prescribed 1,000 items of Montelukast over the last 12 months at a cost of £1,874 to the NHS. This is 46% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
97
Jul 2026
74
Jul 2026
92
Jul 2026
91
Jul 2026
73
Jul 2026
98
Jul 2026
77
Jul 2026
80
Jul 2026
90
Jul 2026
77
Jul 2026
74
Jul 2026
77
Prescribing Details
| Total Items | 1,000 |
|---|---|
| Total Quantity | 36,367 |
| Total NHS Cost | £1,874 |
| Presentations | 5 different forms |
| vs National Average | +46% |
Montelukast Prescribing Comparison
| This practice | 1,000 items |
|---|---|
| National average per practice | 685 items |
| Difference | +46% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.